Adocia
About
History
Management
Board of directors
Advisory board
Products and platforms
Pipeline
Technology Platforms
Careers
The « Adocians »
HR policy
Work environment
Join us
Partnering
Investors
Media
Contact
Contact us
Map and accessibility
Investors
Regulated information
Stock information
Corporate governance
General meeting
Media
Press releases
Media
EN
FR
Adocia reports positive results from phase IIa clinical study of fast-acting human insulin, HinsBet
Previous article
Adocia initiates a clinical study on the post-meal effect of ultra-rapid BioChaperone Lispro insulin formulation
Next article
Adocia: modification of the means allocated to the liquidity agreement
